A
Alexey B. Dyatkin
Researcher at Universal Display Corporation
Publications - 92
Citations - 2042
Alexey B. Dyatkin is an academic researcher from Universal Display Corporation. The author has contributed to research in topics: Catalysis & Layer (electronics). The author has an hindex of 24, co-authored 92 publications receiving 2018 citations. Previous affiliations of Alexey B. Dyatkin include Johnson & Johnson Pharmaceutical Research and Development & Janssen Pharmaceutica.
Papers
More filters
Patent
Carbazole-containing materials in phosphorescent light emitting diodes
TL;DR: Carbazole-containing compounds as mentioned in this paper have an unsymmetrical structure and are useful in organic light emitting devices, in particular as hosts in the emissive layer of such devices.
Journal ArticleDOI
Enantioselective Intramolecular Cyclopropanations of Allylic and Homoallylic Diazoacetates and Diazoacetamides Using Chiral Dirhodium(II) Carboxamide Catalysts
Michael P. Doyle,Richard E. Austin,A. Scott Bailey,Michael P. Dwyer,Alexey B. Dyatkin,A. V. Kalinin,Michelle M. Y. Kwan,Spiros Liras,Christopher J. Oalmann +8 more
TL;DR: In this article, a transition state model was proposed to predict enantioselectivity in intramolecular cyclopropanations of 3-allcyl/aryl-2-Z)-alken-l-y1 diazoacetates.
Patent
Dibenzothiophene-containing materials in phosphorescent light emitting diodes
TL;DR: In this paper, a new class of dibenzothiophene and/or Dibenzofuran-containing compounds are provided, which may be useful in organic light emitting devices, particularly as the host of an emissive layer having a host and a dopant, or as a material in an enhancement layer.
Patent
Sulfonyl-derivatives as novel inhibitors of histone deacetylase
Kristof Van Emelen,Janine Arts,Leo Jacobus Jozef Backx,Hans De Winter,Sven Franciscus Anna Van Brandt,Marc Gustaaf Celine Verdonck,Lieven Meerpoel,Isabelle Noelle Constance Pilatte,Virginie Sophie Poncelet,Alexey B. Dyatkin,Jimmy Arnold Viviane Van heusden +10 more
TL;DR: In this paper, the novel compounds of formula (I) have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
Patent
Inhibitors Of Histone Deacetylase
Kristof Van Emelen,Marc Gustaaf Celine Verdonck,Sven Franciscus Anna Van Brandt,Patrick Angibaud,Lieven Meerpoel,Alexey B. Dyatkin +5 more
TL;DR: In this article, hydroxamic acid derivatives that are inhibitors of histone deacetylase (HDAC) are used for treating cellular proliferative diseases, including cancer, and have antiprotozoal properties.